Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease

BACKGROUND: Non-small cell lung cancer (NSCLC) patients with interstitial lung disease (ILD) need to be approached carefully given the high incidence of pulmonary toxicity. Pemetrexed (PEM) is the key drug for the treatment of NSCLC. However, its safety, especially with respect to the exacerbation o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kato, Motoyasu, Shukuya, Takehito, Takahashi, Fumiyuki, Mori, Keita, Suina, Kentaro, Asao, Tetsuhiko, Kanemaru, Ryota, Honma, Yuichiro, Muraki, Keiko, Sugano, Koji, Shibayama, Rina, Koyama, Ryo, Shimada, Naoko, Takahashi, Kazuhisa
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4107964/
https://ncbi.nlm.nih.gov/pubmed/25012241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-508
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados